These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6370160)

  • 1. Captopril in the treatment of scleroderma renal crisis.
    Thurm RH; Alexander JC
    Arch Intern Med; 1984 Apr; 144(4):733-5. PubMed ID: 6370160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Special uses for captopril.
    Materson BJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):88-93. PubMed ID: 2886046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Administration of angiotensin I converting enzyme inhibitor captopril, in a case of renal crisis of scleroderma--the effects of captopril to the temperature of the skin lesion in scleroderma (author's transl)].
    Gotoh S; Ogihara T; Hata T; Maruyama A; Naka T; Nakamaru M; Mikami H; Masuo K; Kumahara Y
    Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1133-41. PubMed ID: 7033607
    [No Abstract]   [Full Text] [Related]  

  • 4. Captopril in hypertension after renal transplantation.
    Herlitz H; Ahlmén J; Aurell M; Blohmé I; Brynger H; Delin K; Larsson O
    Scand J Urol Nephrol Suppl; 1984; 79():111-4. PubMed ID: 6382584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course of patients with scleroderma renal crisis treated with captopril.
    Zawada ET; Clements PJ; Furst DA; Bloomer HA; Paulus HE; Maxwell MH
    Nephron; 1981; 27(2):74-8. PubMed ID: 7022235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of captopril to reverse the renal crisis of scleroderma.
    Brown EA; Macgregor GA; Maini RN
    Ann Rheum Dis; 1983 Feb; 42(1):52-3. PubMed ID: 6338841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction.
    Wauters JP; Waeber B; Brunner HR; Guignard JP; Turini GA; Gavras H
    Clin Nephrol; 1981 Aug; 16(2):86-92. PubMed ID: 6266727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of Capoten in systemic scleroderma].
    Guseva NG; Anikina NV; Shcherbakov AB
    Ter Arkh; 1992; 64(5):100-2. PubMed ID: 1455361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of renal crisis in progressive systemic sclerosis with captopril].
    Latorre LC; Mion D; Zerbini CA; Pastor EH; Resende C; Fidelis TS; Gabriel Júnior A; Assad RL; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(1):18-21. PubMed ID: 3903950
    [No Abstract]   [Full Text] [Related]  

  • 10. [Improvement in scleroderma kidney with captopril].
    Ben David A; Blau A; Rapoport G
    Harefuah; 1994 Oct; 127(7-8):234-5, 287. PubMed ID: 7813949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant arterial hypertension in scleroderma. Beneficial effects of captopril on pulmonary and systemic vascular resistance].
    Bonnet F; Matamis D; Lepresle E; Cabane J; Le Gall JR
    Nouv Presse Med; 1982 May; 11(20):1570-1. PubMed ID: 7048249
    [No Abstract]   [Full Text] [Related]  

  • 12. Renin-angiotensin system in normotensive and hypertensive patients with progressive systemic sclerosis: hyporesponsiveness of renin during captopril test.
    Guillevin L; Leenhardt A; Godeau P
    Postgrad Med J; 1983; 59 Suppl 3():171-2. PubMed ID: 6359107
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beneficial effect of the converting enzyme inhibitor on the acute renal failure of scleroderma with arterial hypertension].
    Mercatello A; Zech PY
    Nouv Presse Med; 1981 Apr; 10(19):1596. PubMed ID: 7025853
    [No Abstract]   [Full Text] [Related]  

  • 14. [Scleroderma complicated by arterial hypertension and kidney failure: treatment with captopril].
    Flechet ML; Bravard P; Godin M
    Nouv Presse Med; 1981 May; 10(22):1848. PubMed ID: 7015276
    [No Abstract]   [Full Text] [Related]  

  • 15. [Scleroderma complicated by arterial hypertension and renal insufficiency. Favorable effects of captopril].
    Grünfeld JP; Pulik M; Reveillaud RJ; Martinet C
    Nouv Presse Med; 1980 Oct; 9(36):2658. PubMed ID: 7001352
    [No Abstract]   [Full Text] [Related]  

  • 16. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects.
    Costa FV; Borghi C; Ambrosioni E
    Clin Ther; 1984; 6(5):708-18. PubMed ID: 6383615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of accelerated arterial or malignant hypertension with captopril. Value, efficacy and outcome of visceral complications].
    Gonthier R; Berthoux FC
    Ann Med Interne (Paris); 1983; 134(4):300-5. PubMed ID: 6351694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril.
    Waeber B; Schaller MD; Wauters JP; Brunner HR
    Klin Wochenschr; 1984 Aug; 62(15):728-30. PubMed ID: 6387262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resolution of scleroderma renal crisis with thrombotic microangiopathy. Case report (author's transl)].
    Rebaiz K; Birembaut P; Charneau A; Petit J; Wolf C
    Nephrologie; 1980; 1(3):137-41. PubMed ID: 7027064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.